Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..9 of 9 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential.
More
Are you a small to medium company seeking a UK presence?
More
UK partner for strategic divestments
More
Strategic divestments of primary care sales focussed brands
More
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology
More
A global health care group is currently seeking technologies that are able to diagnose health related conditions in consumers.
More
A global OTC Pharma products group is seeking technologies, approaches and materials that are able to prolong adhesion to a mucosal surface of the oral, pharyngeal, throat, nasal and upper & lower respiratory tracts.
More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries.
More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark.
More
Displaying 1..9 of 9 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
Jan 2011 - 33 pages - $500
May 2011 - 81 pages - $3,835
Jan 2011 - 28 pages - $1,000
Dec 2010 - 37 pages - $1,000
Jan 2011 - 22 pages - $500
Dec 2010 - 36 pages - $1,000
Oct 2011 - 60 pages - $500